A Study for the Transdermal Application of Teriparatide
NCT01011556
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
233
Enrollment
INDUSTRY
Sponsor class
Conditions
Osteoporosis
Interventions
DRUG:
Subcutaneous Teriparatide
DRUG:
Transdermal Teriparatide
Sponsor
Eli Lilly and Company
Collaborators
[object Object]